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Complex, indigestible free oligosaccharides as well as conjugated glycans are found in milk that shape the gut
microbiome of infants. The activity of an endo-β-N-acetylglucosaminidase from B. longum subsp. infantis (B.
infantis) is known to release N-glycans from native milk glycoproteins under physiological conditions. We investigated whether this enzyme is active in vivo in breastfed infants fed B. infantis EVC001. Using mass spectrometry, we found 19 N-glycans related to human milk glycoproteins increased in abundance, similar to previous work using bovine milk glycoproteins, and these 19 N-glycans matched unique specificities of this enzyme.
Twenty N-glycans were unique to infants fed B. infantis EVC001. Bifidobacteriaceae were correlated with these
glycans, confirming the relationship between B. infantis and released N-glycans. This suggests that this enzyme is
active in vivo and releases N-glycans from milk glycoproteins, and may play a role in B. infantis EVC001 colonization of the gut microbiome.

1. Introduction
Millenia of evolution have shaped human milk into the nutritionally
ideal food for infants. Stringent selective pressures have shaped the
components of human milk to maximize their functional and nutritional
utility (Garrido et al., 2013). Apart from containing protein, fat, and
carbohydrates that feed the infant, human milk contains a high concentration of oligosaccharides ranging in complexity and composition
(Zivkovic et al., 2011). These oligosaccharides (human milk oligosaccharides, HMOs) represent a major fraction of the total solid fraction
of human milk, though the exact concentration varies across lactation
and between individuals (Smilowitz et al., 2013; Xu et al., 2017). HMOs
are selectively utilized by members of the infant gut microbiome, predominantly by Bacteroides and infant-associated Bifidobacterium, and
uniquely by B. infantis (Garrido et al., 2012; LoCascio et al., 2007;
Matsuki et al., 2016; Sela et al., 2008).
In addition to HMOs, glycans are also found in conjugated forms,
bound to either lipids or proteins. N- and O-linked glycans conjugated
to proteins in human milk may represent a consequential fraction of
complex carbohydrates that is selectively accessible by members of the
distal gut microbiome. The similarity in composition and structural
linkages between HMOs and glycans has led to interest in the functional
role of these bound glycans in modulating the gut microbiome (Garrido
⁎

et al., 2016). Recent work has shown that the N-glycans bound to milk
glycoproteins such as lactoferrin, and immunoglobulins facilitate the
growth of Bifidobacterium longum subsp. infantis (B. infantis; Karav et al.,
2016). Further, these glycans can be released from glycoproteins by the
action of a unique enzyme, endo-β-N-acetylglucosaminidase or (EndoBI-1) found in B. infantis (Garrido et al., 2012). Large genomic islands
found in B. infantis encoding transport and hydrolysis pathways for
human milk glycans enable utilization of glycans released by EndoBI-1
from milk proteins (Garrido et al., 2011; Sela et al., 2008). In addition
to HMOs, these N-glycans are thought to help facilitate colonization of
the infant gut (Garrido et al., 2013).
Recent work showed that infants fed B. longum subsp. infantis
EVC001 (B. infantis EVC001) were colonized at high levels by this organism and substantial changes to the infant gut microbiome and the
metabolic output of this community were also observed. Among infants
colonized by B. infantis EVC001, fecal concentrations of HMOs dropped
significantly as B. infantis EVC001 fermented these oligosaccharides to
primarily lactate and acetate. In contrast, neither the concentrations of
fecal HMOs nor lactate and acetate changed in infants who had not
been fed B. infantis EVC001 over the first month of life (Frese et al.,
2017). We speculated that a homologous endo-β-N-acetylglucosaminidase found in B. infantis EVC001 may be active in vivo and
be evidenced by the release of additional, selectively fermentable N-
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glycans (Karav et al., 2016) that may foster the growth of B. infantis
EVC001 in vivo. In order to determine whether the endo-β-N-acetylglucosaminidase was active on human milk glycoproteins in vivo, we
compared the N-glycan profile of fecal samples from breastfed infants
colonized by B. infantis EVC001 and infants from the control group with
different microbiome compositions lacking B. infantis. We hypothesized
that the activity of an endo-β-N-acetylglucosaminidase (EndoBI-1)
found in B. infantis could be detected by mass spectrometry targeting
the unique N-glycans released from milk glycoproteins.
2. Materials and methods
2.1. Study design and subject characteristics
Fecal samples were collected from breastfed infants at Day 29
postpartum recruited in a previous study (Frese et al., 2017; Smilowitz
et al., 2017). Samples were collected from two groups of infants and
profiled by untargeted mass spectrometry (Karav et al., 2018) and is
described in 2.2. One group was fed 1.8 × 1010 CFU per day of Bifidobacterium longum subsp. infantis EVC001 mixed with breast milk
(EVC001-fed; n = 8), while the other group was fed breast milk alone
(control; n = 10). Patient demographics are reported in detail previously (Karav et al., 2018) but overall, neither the subjects nor their
mothers differed significantly (P > 0.05) across most demographic
measurements. No difference was found between the groups in terms of
among delivery mode (cesarean section or vaginally), duration of labor,
rate of antibiotic administration to mothers during labor, complications
associated with labor, gestational age at delivery, birth weight or
length, sex, provision of antibiotics to infants, pre-pregnancy BMI,
weight gain during pregnancy, group-B Streptococcus diagnosis, or
maternal age. However, more infants in the control group were born to
primiparous mothers (P = 0.01).

Fig. 1. PNGase F and EndoBI-1 are active on different locations relative to the
N-glycan core, resulting in predictably altered N-glycan profiles.

PNGase F, which has a different activity on N-glycan structures. PNGase
F cleaves the bond between the primary N-acetylhexosamine (HexNAc)
and the polypeptide, whereas EndoBI-1 cleaves between the HexNAc
bound to the polypeptide and the second HexNAc (Fig. 1). PNGase F
activity is also limited when an alpha 1,3-fucose is attached to the primary HexNAc. Therefore, libraries obtained from previous studies were
modified based on known differences between the enzymatic activities of
PNGase F and EndoBI-1. Moreover, some free and conjugated glycans
possess the same molecular mass although their chemical structures are
different. Since tandem mass spectrometry was not performed in this
study, these compounds, which could have been derived from either free
or conjugated glycans were not considered during the data analysis and
only unique N-glycan derived structures were examined. Compound
abundances were expressed as volume in ion counts that corresponded to
absolute abundances of the compounds in each sample. Numerical
structural compositions are ordered as Hex-HexNAc-Fuc-NeuAc-NeuGc.

2.2. N-glycan data analysis
Spectra obtained from previously analyzed for colonic mucin-derived
O-glycans were analyzed as described previously (Karav et al., 2018),
except N-glycans were targeted using a library specific for N-glycans
released by the activity of EndoBI-1. The overall approach was previously reported for these samples to determine the concentration of
structurally similar HMOs by mass spectrometry (Frese et al), but instead, the analysis of spectra described here was specifically for N-glycans in this study. Fecal glycans were characterized on a nano‐HPLC‐Chip‐TOF mass spectrometer using the methods previously
described (Davis et al., 2016). As reported previously (Frese et al., 2017),
the high‐performance liquid chromatography (HPLC) system used was an
Agilent 1200 series unit with a microfluidic chip, which was coupled to
an Agilent 6220 series time of flight (TOF) mass spectrometer via chip
cube interface. The sample was introduced into the TOF mass spectrometer via electrospray ionization, which was tuned and calibrated using
a dual nebulizer electrospray source with calibrant ions ranging from m/
z 118.086 to 2721.895, and data were collected in the positive mode
(Davis et al., 2016). Untargeted mass spectra were collected and analyzed using Agilent MassHunter Work station Data Acquisition version
B.02.01 on the nanoHPLC-chip/TOF. The “Find Compounds by Molecular Feature” function of the software was used to identify N-glycan
structures potentially released from human milk glycoproteins by B. infantis EndoBI-1 (endo-β-N-acetlyglucosaminidase). The software generated extracted compound chromatograms in the range of 400 to 3000 m/
z, with an ion count cutoff of 600, allowed charge states of 1–3, retention
times of 5–40 min, and a typical isotopic distribution of small biological
molecules. The relative abundance (area) was calculated using MassHunter Profinder software. Example spectra are shown in Figure S1. To
determine target N-glycan compositions, previously published libraries
were used. However, these libraries were identified by previously validated tandem mass spectrometric analysis of glycans released using

2.3. Microbiome sequencing
As previously described, DNA was extracted from samples for microbiome profiling. To assess how variations in bacterial communities
in the infant gut were related to N-glycan profiles, 16S rDNA sequencing results reported previously from these samples (Frese et al., 2017;
Karav et al., 2018) and deposited in the NCBI SRA (PRJNA390646)
were compared to N-glycan profiles obtained as described above. Sequencing of 16S rDNA amplicons was performed at the UC Davis
Genome Center on an Illumina MiSeq. This resulted in 9216 reads
(SD ± 4505 reads) on average, per sample, after quality filtering (e.g.
removal of low-quality reads or chimeric sequences). The relative
abundance of the dominant bacterial families are shown in Table 3.
2.4. Statistical analysis
Wilcoxon Rank-sum test or Fisher’s Exact test was used for single
comparisons. P values, or FDR-adjusted P values, of 0.05 or less in
comparisons were considered significantly different. Differences in
bacterial community composition and N-glycans were calculated using
principle coordinate analysis (PCoA) and a Bray-Curtis dissimilarity
index between all N-glycan species was visualized via PCoA. To evaluate the effect-size of EVC001 colonization, both weighted UniFrac and
Bray-Curtis dissimilarity matrices were tested via Permanova multivariate comparisons with 999 permutations and FDR-corrected P2
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substantial fraction of the N-glycans found on lactoferrin in vivo. High
mannose, complex and hybrid glycans released from these glycoproteins were all detected.

Table 1
N-glycan families detected in infant fecal samples. The mean ( ± SD) number of
N-glycan isomers found in fecal samples of infants fed EVC001 and control
subjects.
Number of N-glycans detected

Control
( ± SD)

EVC001-fed
( ± SD)

FDR-adjusted
P-value

Total N-glycans
Neutral Complex/Hybrid
Acidic Complex/Hybrid
(Sialylated)
High Mannose

3.8 ± 2.82
3.1 ± 2.38
0.1 ± 0.32

42.37 ± 7.24
25.125 ± 3.14
13.5 ± 4.24

P < 0.001
P < 0.001
P < 0.001

0.7 ± 0.95

3.25 ± 2.71

P < 0.05

3.3. N-glycan compositions are associated with B. infantis colonization
Given that there were significant differences in the abundance and
diversity of N-glycans detected in stools from infants fed B. infantis
EVC001 relative to the controls, the relationship between N-glycan
abundance and diversity was examined in the context of the gut microbiome. We hypothesized that the difference observed between the
two groups was a result of colonization with B. infantis EVC001.
Overall, the gut microbiome composition is known to be predominantly
B. infantis in infants fed B. infantis EVC001 (Table 3), however only
weak associations between overall gut microbiome composition and Nglycan profile were observed for total N-glycans, when compared by
Mantel test (P > 0.05). In contrast, the family Bifidobacteriaceae was
significantly and strongly associated with total N-glycans, 41000,
43000, 43100, and 53000 (Table 4). Together, these N-glycans alone
composed 63.25% ( ± 19.51% SD) of the total N-glycan pool among
fecal samples from infants fed EVC001; notably, in these samples the
total glycan pool is also larger (7.92 Log10 intensity compared to 6.56
Log10 intensity in the control group, P < 0.0001). In comparison, only
16.21% ( ± 23.69%) of the total pool of N-glycans was composed of
these four Bifidobacteriaceae-associated glycans in control infant fecal
samples (P = 0.0033).

values. N-glycan abundance was transformed to dissimilarity matrices
using Euclidean distance while phylogenetic distance was obtained via
the weighted UniFrac algorithm. Tests were performed using Pearson’s
product-moment correlation coefficient (r) with 999 permutations and
a two-tailed test.
3. Results
3.1. N-glycan characterization
N-glycan compositions were determined by the untargeted approach of
nano-HPLC-Chip-TOF. As human milk glycoprotein-derived N-glycans
compositions were previously published, these libraries were used in this
study (Nwosu et al., 2012). A library containing fifty-two N-glycan compositions was compared against the samples. Thirty structures (representing 49 total isomers) were detected. Infants fed EVC001 had a
significantly higher number of distinct N-glycan structures (42.37 ± 7.24)
than the control infants not colonized by EVC001 (3.8 ± 2.82) (Table 1).
Among EVC001-colonized infants, an average of 25 ± 3.13 SD of them
were neutral complex/hybrid, 13.5 ± - 4.24 SD were acidic complex/hybrid (sialylated) and 3.25 ± 2.71 SD were high mannose type of N-glycans. In contrast, control infants had fewer structures, primarily composed
of neutral complex/hybrid N-glycans (3.1 ± 2.06) (Table 1).

4. Discussion
While human milk provides nutrition for the infant, a substantial
fraction of this food is not available as nutrients and serves a key function
in shaping the gut microbiome (Zivkovic et al., 2011). Human milk oligosaccharides (HMOs) have been recognized for playing a major role in
shaping the infant gut microbiome composition, but other glycan sources
from food may play an additional role in the gut (Karav et al., 2016; Lee
et al., 2014). N-glycans were recently shown to be released from milk
glycoproteins by the activity of a unique, extracellular enzyme known as
EndoBI-1, an endo-β-N-acetylglucosaminidase, found in the infant gut
symbiont, B. infantis (Garrido et al., 2012; Karav et al., 2016). Further,
the release of these N-glycans from milk proteins resulted in a freed
glycan pool that was selective for B. infantis, even in comparison to other
Bifidobacterium species, and remarkably, the released glycans were more
effective at stimulating the growth of B. infantis once released from the
protein or peptide, when compared to the intact protein itself or after the
removal of glycans from the protein after pre-treatment with EndoBI-1
(Karav et al., 2016). This suggested that N-glycans released from glycoproteins in vivo may play an outsized role in shaping the microbial
communities by supporting colonization of the infant gut by B. infantis. In
agreement with previous in vitro studies, many of the N-glycans were
significantly more abundant in fecal samples from infants colonized by B.
infantis EVC001 compared to samples from control infants.
Glycan foraging is a noted competitive strategy for colonization by
gut symbionts (Marcobal et al., 2013; Sonnenburg et al., 2005), though
bound glycans such as O-linked glycans on mucin glycoproteins are less
preferred by glycan foragers like Bacteroides, relative to larger, structurally repetitive plant starches and complex regulation of glycan consumption occurs through conserved pathways in some gut symbionts
(Lynch and Sonnenburg, 2012; Marcobal et al., 2011). Unlike common
strategies in these other glycan foragers where these oligosaccharides are
degraded extracellularly to monomers, glycans released by EndoBI-1
under these conditions are released intact and transported by Family-1
Solute binding proteins (F1SBPs; Garrido et al., 2011; Sela et al., 2008) as
a result of their conserved structural features shared with many HMOs.
Previous work in vitro demonstrated that EndoBI-1 releases of
52010, 53010, 44010, 53110, 43000 and 53000 from bovine milk
glycoproteins and that these glycans are specifically utilized by B.

3.2. Relative abundance of N-glycans
The abundance of each of the N-glycan compounds was determined
by peak area (Table 2). Based on these findings, the relative abundance
of samples from infants colonized with EVC001 and control samples were
ranged between 163273 ± 204568 to 27509632 ± 24168794 and 0 to
1986832 ± 1994415, respectively. The most highly abundant compounds detected in EVC001 were 43000, 43100, 53000, 53100, 53200,
53010 and 53310. These compounds are different than a previously
performed analysis based on PNGAse F by Dallas et al. (2011) which
showed the highest abundant N-glycan compositions are 54210, 54110,
54200 and 54300. Differences observed were accounted by a single
HexNAc given a difference in enzyme activity and substrate specificity
between PNGase F, used by Dallas et al. (2011), and EndoBI-1.
The relative abundance of each class of N-glycans was determined
for EVC001-fed infants and control samples are shown in Table 2. Based
on the results, the total relative abundance of neutral complex/hybrid,
acidic complex/hybrid (sialylated) and high mannose glycans of
EVC001 fed samples were significantly different between the two
groups (Table 2, Fig. 2).
These findings show that the majority of glycans detected in
EVC001 fed samples are predicted to originate from lactoferrin and
immunoglobulins (Fig. 3). When the compounds detected in our study
were compared with the lactoferrin N-glycan library, 14 out of 18 Nglycans found in EVC001-fed infants could be attributed to lactoferrin
but not immunoglobulins while a minority of these glycans were of
nonspecific origin (i.e. they could originate from any one of multiple Nlinked glycoproteins such as lactoperoxidase) or from milk immunoglobulins. These results suggest that B. infantis releases a
3
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Table 2
Abundance (peak volume) of N-glycans found in EVC001 fed and control samples. Compositions are ordered by Hex-HexNAc-Fuc-NeuAc-NeuGc.
N-glycan type

N-glycan Code

Composition

m/z

z

m

Volume Control

Volume EVC001 Fed

FDR-adjusted P Value

Neutral Complex/Hybrid

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

41000
52000
43000
43100
53000
52200
53100
53200
63100
35200
45100
45200
36200
65100
36300
52010
64310
52110
62010
44010
53010
53110
44110
53210
53310
51000
61000
81000
91000

436.74
618.23
639.74
712.76
720.77
764.33
793.80
866.83
874.33
907.12
915.18
988.24
1008.81
1077.90
1081.77
764.33
811.11
837.83
845.65
886.82
866.31
939.34
959.85
1012.37
1085.90
1034.37
598.21
760.09
841.13

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
2
2
2
2
2
2
2
2
1
2
2
2

871.48
1236.45
1277.47
1423.53
1439.53
1526.66
1585.59
1731.64
1747.68
1825
1829.49
1975.4
2015.62
2153.79
2161.55
1526.66
2534.2
1673.65
1689.29
1771.64
1731.62
1876.67
1917.70
2023.73
2169.79
1033.37
1195.42
1519.1
1681.25

0±0
0±0
0±0
342,923 ± 731,341
256,653 ± 541,647
0±0
925328 ± 1334063
1,986,832 ± 1994415
0±0
0±0
0±0
0±0
0±0
0±0
0±0
0±0
0±0
0±0
0±0
0±0
17,234 ± 54499
0±0
0±0
20230.4 ± 63974
19,345 ± 61175
19,213 ± 60758
0±0
20,108 ± 63,589
0±0
3,511,738 ± 3,085,141
56,810 ± 91,761
39,322 ± 82,925
3,607,870 ± 3,096,536

984,402 ± 539,230
727,585 ± 740,910
16,336,429 ± 12,518,995
11,473,565 ± 7,892,814
27,509,632 ± 24168794
170,903 ± 267358
4347701 ± 5648944
5545213 ± 5803780
311,166 ± 442663
306844 ± 402042
209082 ± 277573
256041 ± 346230
687310 ± 832357
458324 ± 711077
154200 ± 173,652
568612 ± 870952
942611 ± 1506753
163273 ± 204568
406477 ± 797280
613252 ± 1069722
2263998 ± 3337414
788923 ± 1468401
817721 ± 1201857
2374434 ± 3643257
2594002 ± 3763059
191175 ± 294378
400248 ± 573039
207,358 ± 330,429
433,937 ± 481,589
69,478,405 ± 48,954,788
11,533,306 ± 8,831,971
1,232,719 ± 1,377,197
82,244,430 ± 55,275,913

0.0037
0.0196
0.0037
0.0037
0.0088
0.0568
0.0986
0.1290
0.0568
0.0260
0.0260
0.0260
0.0260
0.0260
0.0260
0.0196
0.0568
0.0260
0.0260
0.0568
0.0196
0.1309
0.0196
0.0260
0.0260
0.1481
0.0568
0.1796
0.0260
< 0.001
< 0.001
< 0.01
< 0.001

Acidic Complex/Hybrid (Sialylated)

High Mannose
Neutral Complex/Hybrid
Acidic Complex/Hybrid (Sialylated)
High Mannose
All Glycans

Fig. 2. Both the total area of all N-glycans and the combined area of all N-glycans as categories in three major subcategories (acidic complex/hybrid, neutral
complex/hybrid, or high mannose) were significantly increased among infants fed EVC001 (teal boxplot), relative to the N-glycome found in control (grey boxplot)
infants. (P < 0.05, *; P < 0.01, **; P < 0.001, ***).
4
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Fig. 3. Extracted compound chromatograms (ECC) for N-glycans predicted to be released from lactoferrin (LF), immunoglobulins (IG), or from shared N-glycans
(including other milk glycoproteins). Purple, red and green peaks represent LF N-glycans, immunoglobulin N-glycans and mutual N-glycans for both glycoproteins,
respectively. For the illustration of N-glycan structures, green circles, yellow circles, blue squares, red triangles and purple diamonds represent mannose, galactose,
HexNAc, Fucose and NeuAc residues, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)

infantis EVC001 is 5.1 (Frese et al., 2017; Henrick et al., 2018) and,
together with the infant’s approximate body temperature of 37 °C, these
conditions mirror the previously determined optimum conditions for
the enzyme, which enabled the release of these glycans from homologous bovine milk glycoproteins in vitro (Karav et al., 2015). Together,
these results suggest that the enzyme is not only expressed in vivo but
the conditions experienced in vivo as a result of colonization by B. infantis are similar to the enzyme's optimum previously determined empirically in vitro.
Under these conditions, the growth of Enterobacteriaceae in the infant gut is limited as a result of the canonical fermentation of carbohydrates to acetate and lactate by Bifidobacterium (Pokusaeva et al.,
2011) thereby reducing fecal pH (Fukuda et al., 2011; Sorbara et al.,
2019; Henrick et al., 2018). While we negatively correlated the abundance of Enterobacteriaceae and Bacteroidaceae with these glycans, it is
unclear from these findings whether these structures directly affect the
abundance of these taxa, or perhaps more likely, the abundance of these
glycans is positively associated with B. infantis EVC001 colonization
and contribute to the creation of conditions which disfavor the growth
of Gram negative organisms. However, previous work has shown that
N-glycans from milk proteins such as lactoferrin inhibit the adhesion of
some enteric pathogens to gut epithelial cells and contribute to the
antimicrobial activity of lactoferrin itself (Barboza et al., 2012; Karav,
2018). Further, the removal of N-glycans from proteins reduces resistance of the protein to protease degradation, resulting in the production of additional bioactive peptides from milk proteins (Garrido
et al., 2013; Van Berkel et al., 1995) and which may limit the growth of
potential enteropathogens.

Table 3
Mean relative abundance (percent, ± SD) of predominant bacterial families in
infant fecal samples from both groups.
Bacterial family

Control

EVC001-fed

Bifidobacteriaceae
Bacteroidaceae
Enterobacteriaceae
Clostridiaceae
Lachnospiraceae
Streptococcaceae
Staphylococcaceae
Veillonellaceae
Enterococcaceae
Other

26.69 (24.23)
21.63 (14.28)
19.02 (20.91)
11.27 (17.15)
7.4 (18.2)
2.24 (2.17)
1.49 (2.14)
1.12 (2.68)
0.52 (0.64)
8.64 (7.4)

96.02 (2.69)
0.02 (0.05)
0.77 (1.14)
0 (0)
0.01 (0.01)
1.91 (2.14)
0.4 (0.37)
0.24 (0.6)
0.19 (0.45)
0.44 (0.49)

Table 4
Correlational analysis comparing microbiome composition (Mantel test) and
significantly associated bacterial families (Spearman’s ρ) with fecal N-glycans.
Structural compositions are ordered as Hex-HexNAc-Fuc-NeuAc-NeuGc.
N-glycan
structures

Mantel r

Mantel
P-value

Bacterial family

Spearman’s ρ

FDRadjusted
P-value

Total

0.11

0.19

41000

0.23

0.05

43000

0.09

0.38

43100

0.11

0.33

Bifidobacteriaceae
Enterobacteriaceae
Bifidobacteriaceae
Enterobacteriaceae
Bacteroidaceae
Bifidobacteriaceae
Enterobacteriaceae
Bacteroidaceae
Bifidobacteriaceae

0.70
−0.6
0.78
−0.77
−0.69
0.82
−0.74
−0.65
0.72

0.02
0.02
< 0.001
< 0.001
0.01
< 0.001
0.003
0.02
0.01

53000

0.05

0.79

Bifidobacteriaceae
Enterobacteriaceae
Lactobacillaceae

0.83
−0.82
−0.63

< 0.001
< 0.001
0.03

5. Conclusion
Here, we show that an enzyme produced by a human gut symbiont,
B. infantis, with unique function and structural specificity for the release
of N-linked glycans found on milk glycoproteins is active under conditions encountered in vivo. The N-glycans produced by the activity of
this enzyme are significantly more abundant and varied among infants
fed B. infantis EVC001. Neutral complex/hybrid, acidic complex/hybrid, and high mannose glycans released by the activity of this enzyme
are all significantly more abundant among infants fed B. infantis

infantis in vitro (Karav et al., 2016). Here we also detect all four of these
glycans in vivo from exclusively breastfed infants and find that all but
one (53110; Table 2) are significantly more abundant among fecal
samples from infants fed EVC001, compared to samples from control
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